While Chinese artificial intelligence startup Tianrang has raised a RMB180 million ($26.3 million) round co-led by Gaorong Capital and CMB International, biotech firm CureGenetics has announced a $17 million Series A led by Qiming Venture Partners.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
